These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11535738)

  • 1. Parenchymal mean transit time analysis.
    Britton KE
    J Nucl Med; 2001 Sep; 42(9):1439-40. PubMed ID: 11535738
    [No Abstract]   [Full Text] [Related]  

  • 2. Parenchymal mean transit time analysis of 99mTc-DTPA captopril renography.
    Fine EJ; Li Y; Blaufox MD
    J Nucl Med; 2000 Oct; 41(10):1627-31. PubMed ID: 11037990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tc-99m-DTPA captopril renography in the detection of renovascular hypertension due to renal polar artery stenosis.
    Ergün EL; Cağlar M
    Ann Nucl Med; 2001 Apr; 15(2):167-70. PubMed ID: 11448078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of renal artery stenosis after transplantation: can losartan be more accurate than captopril renography?
    Fuster D; Paz Marco M; Setoain FJ; Oppenheimer F; Lomeña F
    Clin Nucl Med; 1998 Nov; 23(11):731-4. PubMed ID: 9814557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renovascular hypertension and double renal arterial supply diagnosed by Tc-99m MAG3 captopril renography.
    Morel O; Métrard G; Jeanguillaume C; Rakotonirina H; Blaire T; Le Jeune JJ; Jallet P
    Clin Nucl Med; 2006 May; 31(5):298-300. PubMed ID: 16622344
    [No Abstract]   [Full Text] [Related]  

  • 6. Captopril renal scintigraphy: a viewpoint.
    Dondi M; Fanti S; Monetti N
    J Nucl Biol Med (1991); 1993 Dec; 37(4):259-63. PubMed ID: 8172970
    [No Abstract]   [Full Text] [Related]  

  • 7. Steady-state captopril renography: continuous monitoring of the captopril-induced increase in 99mTc-MAG3 mean parenchymal transit time in renovascular hypertension.
    Esper IE; Chajari M; Fonroget J; Neveu JP; Makdassi R; Bailly P; Fournier A
    Eur J Nucl Med; 1997 Jul; 24(7):739-44. PubMed ID: 9211759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of captopril renography in renovascular hypertension.
    Oei HY; Geyskes GG; Mees EJ; Puylaert CB
    Contrib Nephrol; 1987; 56():95-103. PubMed ID: 3301206
    [No Abstract]   [Full Text] [Related]  

  • 9. Prospective study of simultaneous orthoiodohippurate and diethylenetriaminepentaacetic acid captopril renography. The Einstein/Cornell Collaborative Hypertension Group.
    Blaufox MD; Fine EJ; Heller S; Hurley J; Jagust M; Li Y; Mann SJ; Pickering TG; Zanzonico P; Zhang CG
    J Nucl Med; 1998 Mar; 39(3):522-8. PubMed ID: 9529303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Captopril renography in the diagnosis of renovascular hypertension].
    Jensen JJ; Møller ML; Lund JO; Trap-Jensen J
    Ugeskr Laeger; 1991 Jun; 153(23):1648-51. PubMed ID: 2058027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with the renal scintigraphic captopril test in an elderly population.
    Chaudhuri TK; Fink S
    Am J Physiol Imaging; 1989; 4(1):28-31. PubMed ID: 2647111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radionuclide scintirenography in the evaluation of patients with hypertension. American College of Cardiology position statement.
    Sheps SG; Blaufox MD; Nally JV; Textor SC
    J Am Coll Cardiol; 1993 Mar; 21(3):838-9. PubMed ID: 8382230
    [No Abstract]   [Full Text] [Related]  

  • 13. False-positive captopril renography in patients taking calcium antagonists.
    Claveau-Tremblay R; Turpin S; De Braekeleer M; Brassard A; Leblond R
    J Nucl Med; 1998 Sep; 39(9):1621-6. PubMed ID: 9744356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium channel blockers: a potential cause of false-positive captopril renography.
    Ludwig V; Martin WH; Delbeke D
    Clin Nucl Med; 2003 Feb; 28(2):108-12. PubMed ID: 12544126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Captopril-stimulated renography versus renal vein renins in two-kidney, two-clip hypertension.
    Nally JV; Bedoya LA; Park CH; Martinez A; Stowe NT
    Contrib Nephrol; 1990; 79():176-80. PubMed ID: 2225857
    [No Abstract]   [Full Text] [Related]  

  • 16. Interactive functional imaging of renal scintigraphy after captopril in the detection of global and segmental hypoperfusion.
    Fommei E; Bellina R; Bertelli P; Gazzetti P; Palla L; Ragazzini A; Ghione S
    Contrib Nephrol; 1987; 56():111-6. PubMed ID: 3038462
    [No Abstract]   [Full Text] [Related]  

  • 17. Technetium-99m-ethylenedicysteine: an alternative agent to detect renovascular hypertension.
    Ugur O; Peksoy I; Caner B
    J Nucl Med; 1997 Oct; 38(10):1662-4. PubMed ID: 9379214
    [No Abstract]   [Full Text] [Related]  

  • 18. The investigation of renovascular hypertension in children: the accuracy of radio-isotopes in detecting renovascular disease.
    Ng CS; de Bruyn R; Gordon I
    Nucl Med Commun; 1997 Nov; 18(11):1017-28. PubMed ID: 9423201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interobserver reproducibility in the interpretation of captopril renograms from patients suspected of having renovascular hypertension.
    Tondeur M; Sand A; Ham H
    Clin Nucl Med; 2004 Aug; 29(8):479-84. PubMed ID: 15249823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal captopril renogram in a patient without renovascular hypertension.
    Pelsang RE; Rezai K
    Clin Nucl Med; 1992 Apr; 17(4):303-5. PubMed ID: 1572120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.